1. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products

   • A. Ceci
   • M. Felisi
   • G. Rondini

   Special Article Pages: 495 - 500

2. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia

   • M. Koter
   • M. Broncel
   • I. Franiak

   Pharmacodynamics Pages: 501 - 506

3. Population pharmacokinetics of cisapride in neonates

   • F. Odoul
   • C. Le Guellec
   • E. Autret-Leca

   Pharmacokinetics and Disposition Pages: 507 - 513

4. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers

   • Hege Christensen
   • Anders Åsberg
   • Knut Berg

   Pharmacokinetics and Disposition Pages: 515 - 520

5. Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies

   • C. Kumana
   • W. Au
   • Y. Kwong

   Pharmacokinetics and Disposition Pages: 521 - 526

6. The effect of fluconazole on the pharmacokinetics of rosuvastatin

   • K. Cooper
   • P. Martin
   • M. Cantarini

   Pharmacokinetics and Disposition Pages: 527 - 531

7. CYP2D6 extensive, intermediate, and poor phenotypes and genotypes in a Polish population

   • P. Niewinski
   • K. Orzechowska-Juzwenko
   • Z. Forkasiewicz

   Pharmacokinetics and Disposition Pages: 533 - 535

8. Cytochrome P ₄₅₀ 1A1/2 induction by antiparasitic drugs: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells

   • Tashinga E. Bapiro
   • Tommy B. Andersson
   • Collen M. Masimirembwa

   Pharmacokinetics and Disposition Pages: 537 - 542

9. Polymorphic oxidative metabolism of proguanil in a Nigerian population

   • O. Bolaji
   • I. Sadare
   • F. Ogunbona

   Pharmacokinetics and Disposition Pages: 543 - 545

10. Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001:change over time

    • Per E. Wändell
    • Catharina Gåfvels

    Pharmacoepidemiology and Prescription Pages: 547 - 553

11. Analysis of CYP2C9*5 in Caucasian, Oriental and Black-African populations

    • Ümit Yasar
    • Eleni Aklillu
    • Agneta Wennerholm

    Short Communication Pages: 555 - 558

12. Multivariate cluster analysis of a human hepatic cytochrome P ₄₅₀ database

    • Sherwin K. Sy
    • James A. Johnston
    • Bing-Kou Tang

    Letter to the Editors Pages: 559 - 562

13. Cyclosporin A pharmacokinetics in a patient with psoriasis and obesity, presenting with high levels of low-destiny lipoprotein

    • Tomoki Okuda
    • Tsunao Oh-i

    Erratum Pages: 563 - 563

14. P.D. Hansten, J.R. Horn: The top 100 drug interactions. A guide to patient management

    • Olav Spigset

    Book Review Pages: 565 - 565

15. Newsletter September 2002

    Newsletter 21 November 2002 Pages: S105 - S108